skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hinsveiflur og heilahimnubólur og hliðstæður - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 10 mg/5 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 10 mg/5 mg
oxikodon depot actavis forðatafla 20 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg
oxycodone alvogen (oxycodone ratiopharm) forðatafla 80 mg
alvogen ehf. - oxycodonum hýdróklóríð - forðatafla - 80 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 20 mg/10 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 20 mg/10 mg
cortiment forðatafla 9 mg
ferring lægemidler a/s - budesonidum inn - forðatafla - 9 mg
oxikodon depot actavis forðatafla 40 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 40 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 5 mg/2,5 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 5 mg/2,5 mg
oxikodon depot actavis forðatafla 10 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 10 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 40 mg/20 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 40 mg/20 mg